José Luis Lanciego Pérez-rekin lankidetzan egindako argitalpenak (2)

2025

  1. FKBP51 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson's disease

    Molecular Therapy, Vol. 33, Núm. 3, pp. 895-916

2014

  1. GPR40 activation leads to CREB and ERK phosphorylation in primary cultures of neurons from the mouse CNS and in human neuroblastoma cells

    Hippocampus, Vol. 24, Núm. 7, pp. 733-739